{
  "doc_id": "e7702d64ac2b8ac545ff079f251349c5aa6f21e709e0ed2afb962887b4ca214e",
  "chunk_entities": [
    {
      "chunk_id": "47bb024e1d81584f668209b323886751",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "tree",
          "context": "featuring a tree"
        }
      ]
    },
    {
      "chunk_id": "43728cbddb07f9814ad733e099805822",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "glutamate receptor agonists"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate receptor agonists",
          "context": "different glutamate receptor agonists"
        }
      ]
    },
    {
      "chunk_id": "fe2f33690158486812eee19471bac20d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "Zembrin\u00ae ex vivo"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "all alkaloids in vitro"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuated the amplitude of the population spike",
          "context": "alkaloids in vitro attenuated the amplitude of the population spike"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "Only Mesembranol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "and Mesembrenol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "hydroxyl group",
          "context": "having a hydroxyl group at position C6"
        },
        {
          "entity_type": "Compound",
          "entity_name": "carbonyl group",
          "context": "instead of carbonyl group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrine",
          "context": "as in mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mesembrenone",
          "context": "and mesembrenone"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuation of AMPA receptor mediated transmission",
          "context": "acted by attenuation of AMPA receptor mediated transmission"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPA receptor",
          "context": "attenuation of AMPA receptor mediated transmission"
        }
      ]
    },
    {
      "chunk_id": "9bda7a684a4da1f71309956b2a69bfa8",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "ionotropic glutamate receptors",
          "context": "ionotropic or metabotropic glutamate receptors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "metabotropic glutamate receptors",
          "context": "ionotropic or metabotropic glutamate receptors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "glutamate receptors"
        }
      ]
    },
    {
      "chunk_id": "09951088061ee03731f572bcc75dcc2d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "ACSF",
          "context": "The preparation was superfused with ACSF"
        },
        {
          "entity_type": "Effect",
          "entity_name": "potentiation mechanisms",
          "context": "to avoid potentiation mechanisms"
        },
        {
          "entity_type": "Effect",
          "entity_name": "long-term potentiation",
          "context": "long-term potentiation was induced"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "5 mg/kg",
          "context": "administration by gavage of 5 mg/kg"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "10 mg/kg",
          "context": "or 10 mg/kg Zembrin\u00ae"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "10 mg/kg Zembrin\u00ae or vehicle"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate receptor agonists",
          "context": "concentrations of glutamate receptor agonists"
        }
      ]
    },
    {
      "chunk_id": "cb73daeb66fff4434e766dba6d092166",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "AMPA (\u03b1-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid)",
          "context": "AMPA (\u03b1-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) receptor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "interference of Zembrin\u00ae with AMPA receptor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "(S)-(-)-5-Fluorowillardine",
          "context": "presence of (S)-(-)-5-Fluorowillardine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "agonist",
          "context": "selective competitive AMPA receptor agonist"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.10 \u03bcM",
          "context": "presence of 0.10 \u03bcM (S)-(-)-5-Fluorowillardine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "(S)-(-)-5-Fluorowillardine",
          "context": "0.10 \u03bcM (S)-(-)-5-Fluorowillardine"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "5 mg/kg",
          "context": "one week with 5 mg/kg of Zembrin\u00ae"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "5 mg/kg of Zembrin\u00ae"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "slices from Zembrin\u00ae pre-treated animals"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "interaction of Zembrin\u00ae with AMPA receptor"
        }
      ]
    },
    {
      "chunk_id": "db633bfbf2ece105d4f5e12cb854ecd8",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenone",
          "context": "Mesembrenone Mesembrenol Mesembrine MesembranolChemical structures"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "Mesembrenone Mesembrenol Mesembrine MesembranolChemical structures"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Mesembrenone Mesembrenol Mesembrine MesembranolChemical structures"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "Mesembrenone Mesembrenol Mesembrine MesembranolChemical structures"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenone",
          "context": "four Zembrin\u00ae alkaloids: Mesembrenone"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "four Zembrin\u00ae alkaloids: Mesembrenol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "four Zembrin\u00ae alkaloids: Mesembrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "four Zembrin\u00ae alkaloids: Mesembranol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "four Zembrin\u00ae alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "quinoline ring",
          "context": "a quinoline ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methoxy groups",
          "context": "two methoxy groups (OCH3)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "OCH3",
          "context": "methoxy groups (OCH3)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "piperidine ring",
          "context": "connected to a piperidine ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenone",
          "context": "Mesembrenone has a ketone group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ketone group",
          "context": "a ketone group (C=O)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "C=O",
          "context": "a ketone group (C=O)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "piperidine ring",
          "context": "4-position of the piperidine ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "Mesembrenol has a hydroxyl group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "hydroxyl group",
          "context": "a hydroxyl group (OH)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "OH",
          "context": "a hydroxyl group (OH)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Mesembrine and Mesembranol have a cyclohexane ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "Mesembrine and Mesembranol have a cyclohexane ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclohexane ring",
          "context": "a cyclohexane ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "piperidine ring",
          "context": "instead of a piperidine ring"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ketone group",
          "context": "with a ketone group"
        },
        {
          "entity_type": "Compound",
          "entity_name": "hydroxyl group",
          "context": "and a hydroxyl group"
        }
      ]
    },
    {
      "chunk_id": "208bc740fd45cedb24fc42a5719b81e6",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenone",
          "context": "Mesembrenone 17.14 / 34.80 nmol"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "17.14 / 34.80 nmol",
          "context": "Mesembrenone 17.14 / 34.80 nmol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "Mesembrenol 17.29 / 34.58 nmol"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "17.29 / 34.58 nmol",
          "context": "Mesembrenol 17.29 / 34.58 nmol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Mesembrine 3.46 / 8.65 nmol"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "3.46 / 8.65 nmol",
          "context": "Mesembrine 3.46 / 8.65 nmol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "Mesembranol 17.16 / 34.32 nmol"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "17.16 / 34.32 nmol",
          "context": "Mesembranol 17.16 / 34.32 nmol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ACSF",
          "context": "five conditions: ACSF"
        }
      ]
    },
    {
      "chunk_id": "2b34f704114f6bf5307eda1518c47c45",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Fluorowillardine",
          "context": "presence of Fluorowillardine alone"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "together with the four Zembrin\u00ae alkaloids"
        }
      ]
    },
    {
      "chunk_id": "fa413ea433c4451670531b78c7417767",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "new physiological effect of Zembrin\u00ae"
        },
        {
          "entity_type": "Effect",
          "entity_name": "new physiological effect",
          "context": "revealed a new physiological effect of Zembrin\u00ae"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuated",
          "context": "pyramidal cells was attenuated"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "administration of Zembrin\u00ae"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "5 and 10 mg/kg orally",
          "context": "Single doses of 5 and 10 mg/kg orally"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduce spectral power",
          "context": "significantly reduce spectral power"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "5 - maximum 10 times higher dosages",
          "context": "5 - maximum 10 times higher dosages in rats"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "5 mg/kg in rats",
          "context": "5 mg/kg in rats correspond to 0.5\u20131 mg/kg in humans"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.5\u20131 mg/kg in humans",
          "context": "correspond to 0.5\u20131 mg/kg in humans"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "50 mg",
          "context": "well to the 50 mg"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "5 and 10 mg/kg of Zembrin\u00ae",
          "context": "These doses of 5 and 10 mg/kg of Zembrin\u00ae"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "10 mg/kg of Zembrin\u00ae"
        },
        {
          "entity_type": "Effect",
          "entity_name": "down-regulated the excitability",
          "context": "obviously down-regulated the excitability of the intra-hippocampal neurotransmission"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "using glutamate as transmitter"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPA receptor",
          "context": "Mainly AMPA receptor mediated transmission"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuated",
          "context": "AMPA receptor mediated transmission was attenuated"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA receptor",
          "context": "less NMDA receptor mediated transmission"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuation of the population spike amplitudes",
          "context": "attenuation of the population spike amplitudes induced by repetitive Zembrin\u00ae administration"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "repetitive Zembrin\u00ae administration"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Glutamatergic AMPA receptor",
          "context": "Glutamatergic AMPA receptor"
        }
      ]
    },
    {
      "chunk_id": "68bb909c68065849b6e9005549356007",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "Zembrin\u00ae is able to modulate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "action of Zembrin\u00ae with this transmitter activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serotonin",
          "context": "inhibition of reuptake of serotonin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase 4",
          "context": "inhibition of phosphodiesterase 4 (PDE4)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "phosphodiesterase 4 (PDE4)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "action of Zembrin\u00ae on the glutamatergic system"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "intake of Zembrin\u00ae indicate a significant calming action"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition of reuptake of serotonin",
          "context": "namely inhibition of reuptake of serotonin"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition of phosphodiesterase 4",
          "context": "and inhibition of phosphodiesterase 4"
        },
        {
          "entity_type": "Effect",
          "entity_name": "calming",
          "context": "physiological calming and neuroprotective action"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neuroprotective",
          "context": "calming and neuroprotective action"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-depressive effect",
          "context": "point more to a possible anti-depressive effect"
        },
        {
          "entity_type": "Effect",
          "entity_name": "calming action",
          "context": "indicate a significant calming action"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-anxiety effect",
          "context": "also an anti-anxiety effect"
        },
        {
          "entity_type": "Disease",
          "entity_name": "stress",
          "context": "coping with stress"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "6 weeks duration",
          "context": "repetitive intake of 6 weeks duration"
        }
      ]
    },
    {
      "chunk_id": "264eb19b5505ef99caa5df2b433a25b0",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "a considerable number of alkaloids have been described"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "among them Mesembranol"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "extracts of Sceletium tortuosum"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuate the amplitude of the population spike",
          "context": "able to attenuate the amplitude of the population spike"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "observed for the whole extract (Zembrin\u00ae)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "change the frequency pattern of rat field potentials",
          "context": "all four alkaloids change the frequency pattern of rat field potentials"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "10 \u00b5g/kg",
          "context": "a very low dosage of 10 \u00b5g/kg"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cross the blood brain barrier",
          "context": "proofed to be able to cross the blood brain barrier"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrine",
          "context": "Mesembrine, Mesembrenone, Mesembrenol and Mesembranol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenone",
          "context": "Mesembrine, Mesembrenone, Mesembrenol and Mesembranol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "Mesembrine, Mesembrenone, Mesembrenol and Mesembranol"
        }
      ]
    },
    {
      "chunk_id": "39943db06675d473363628d71dde9a2e",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "of the four alkaloids would more selectively act"
        },
        {
          "entity_type": "Effect",
          "entity_name": "AMPA-mediated neurotransmission",
          "context": "act on AMPA-mediated neurotransmission"
        },
        {
          "entity_type": "Compound",
          "entity_name": "total plant extract",
          "context": "as shown for the total plant extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPA agonist Fluorowillardine",
          "context": "action of the AMPA agonist Fluorowillardine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Fluorowillardine",
          "context": "prevent the action of Fluorowillardine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenol",
          "context": "only Mesembrenol and Mesembranol were able to prevent the action of Fluorowillardine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembranol",
          "context": "only Mesembrenol and Mesembranol were able to prevent the action of Fluorowillardine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "total extract",
          "context": "as observed for the total extract"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "nanomolar range",
          "context": "effective in the nanomolar range"
        },
        {
          "entity_type": "Effect",
          "entity_name": "physiological calming action",
          "context": "responsible for the physiological calming action of Zembrin\u00ae"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Zembrin\u00ae",
          "context": "calming action of Zembrin\u00ae"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mesembrenone",
          "context": "why Mesembrenone in the presence of Fluorowillardine induces"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increase of the population spike",
          "context": "induces a statistically significant increase of the population spike"
        },
        {
          "entity_type": "Compound",
          "entity_name": "active components",
          "context": "that the active components remain attached to the relevant receptors"
        }
      ]
    },
    {
      "chunk_id": "bfad84e350b77f42e8f6b6fb6f6629ad",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "phytochemical content",
          "context": "Investigation of the phytochemical content of Sceletium tortuosum"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "Investigation of the phytochemical content of Sceletium tortuosum"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Ganglioside",
          "context": "Ganglioside regulation of AMPA receptor trafficking"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPA receptor",
          "context": "Ganglioside regulation of AMPA receptor trafficking"
        },
        {
          "entity_type": "Effect",
          "entity_name": "regulation of AMPA receptor trafficking",
          "context": "Ganglioside regulation of AMPA receptor trafficking"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate receptor channels",
          "context": "The molecular biology of mammalian glutamate receptor channels"
        },
        {
          "entity_type": "Effect",
          "entity_name": "effects of temperature on synaptic transmission",
          "context": "The effects of temperature on synaptic transmission in hippocampal tissue slices"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Sceletium alkaloids",
          "context": "Isolation of Sceletium alkaloids by high-speed countercurrent chromatography"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "Isolation of Sceletium alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Sceletium tortuosum alkaloids",
          "context": "The chemotypic variation of Sceletium tortuosum alkaloids"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "The chemotypic variation of Sceletium tortuosum alkaloids"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Psychoactive constituents",
          "context": "Psychoactive constituents of the genus Sceletium N.E.Br."
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium N.E.Br.",
          "context": "constituents of the genus Sceletium N.E.Br."
        },
        {
          "entity_type": "Plant",
          "entity_name": "Mesembryanthemaceae",
          "context": "other Mesembryanthemaceae"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Psychoactive",
          "context": "Psychoactive constituents of the genus Sceletium N.E.Br."
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPA receptor antagonist",
          "context": "The AMPA receptor antagonist perampanel"
        },
        {
          "entity_type": "Compound",
          "entity_name": "perampanel",
          "context": "The AMPA receptor antagonist perampanel"
        },
        {
          "entity_type": "Effect",
          "entity_name": "adjunctive treatment",
          "context": "in the adjunctive treatment of partial-onset seizures"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antagonist",
          "context": "The AMPA receptor antagonist perampanel"
        },
        {
          "entity_type": "Disease",
          "entity_name": "partial-onset seizures",
          "context": "adjunctive treatment of partial-onset seizures"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Medicinal Plants",
          "context": "Medicinal Plants of the World"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Medicinal",
          "context": "Medicinal Plants of the World"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-malarial",
          "context": "developing an anti-malarial phytomedicine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phytomedicine",
          "context": "an anti-malarial phytomedicine"
        },
        {
          "entity_type": "Disease",
          "entity_name": "malaria",
          "context": "an anti-malarial phytomedicine"
        }
      ]
    }
  ],
  "total_entities": 157,
  "extraction_date": "2026-02-01T08:46:22.219260+00:00"
}